BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cario-Toumaniantz C, Boularan C, Schurgers LJ, Heymann MF, Le Cunff M, Léger J, Loirand G, Pacaud P. Identification of differentially expressed genes in human varicose veins: involvement of matrix gla protein in extracellular matrix remodeling. J Vasc Res 2007;44:444-59. [PMID: 17643059 DOI: 10.1159/000106189] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Toumaniantz G, Ferland-mccollough D, Cario-toumaniantz C, Pacaud P, Loirand G. The Rho protein exchange factor Vav3 regulates vascular smooth muscle cell proliferation and migration. Cardiovascular Research 2010;86:131-40. [DOI: 10.1093/cvr/cvp387] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
2 Zhang J, Ma Z, Yan K, Wang Y, Yang Y, Wu X. Matrix Gla Protein Promotes the Bone Formation by Up-Regulating Wnt/β-Catenin Signaling Pathway. Front Endocrinol (Lausanne) 2019;10:891. [PMID: 31920993 DOI: 10.3389/fendo.2019.00891] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
3 Carbone ML, Brégeon J, Devos N, Chadeuf G, Blanchard A, Azizi M, Pacaud P, Jeunemaître X, Loirand G. Angiotensin II activates the RhoA exchange factor Arhgef1 in humans. Hypertension 2015;65:1273-8. [PMID: 25870189 DOI: 10.1161/HYPERTENSIONAHA.114.05065] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
4 Bharath V, Kahn SR, Lazo-langner A. Genetic polymorphisms of vein wall remodeling in chronic venous disease: a narrative and systematic review. Blood 2014;124:1242-50. [DOI: 10.1182/blood-2014-03-558478] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
5 Weissen‐plenz G, Nitschke Y, Rutsch F. Chapter 7 Mechanisms of Arterial Calcification. Elsevier; 2008. pp. 263-93. [DOI: 10.1016/s0065-2423(08)00407-1] [Cited by in Crossref: 37] [Article Influence: 2.6] [Reference Citation Analysis]
6 Vassalle C, Iervasi G. New insights for matrix Gla protein, vascular calcification and cardiovascular risk and outcome. Atherosclerosis 2014;235:236-8. [PMID: 24861727 DOI: 10.1016/j.atherosclerosis.2014.04.037] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
7 Dalmeijer GW, van der Schouw YT, Magdeleyns EJ, Vermeer C, Verschuren WM, Boer JM, Beulens JW. Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients. Diabetes Care 2013;36:3766-71. [PMID: 23877986 DOI: 10.2337/dc13-0065] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 7.6] [Reference Citation Analysis]
8 Xiao Y, Huang Z, Yin H, Zhang H, Wang S. Desmuslin gene knockdown causes altered expression of phenotype markers and differentiation of saphenous vein smooth muscle cells. J Vasc Surg 2010;52:684-90. [PMID: 20573469 DOI: 10.1016/j.jvs.2010.03.069] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
9 Krysa J, Jones GT, van Rij AM. Evidence for a genetic role in varicose veins and chronic venous insufficiency. Phlebology 2012;27:329-35. [PMID: 22308533 DOI: 10.1258/phleb.2011.011030] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
10 Zalewski DP, Ruszel KP, Stępniewski A, Gałkowski D, Bogucki J, Komsta Ł, Kołodziej P, Chmiel P, Zubilewicz T, Feldo M, Kocki J, Bogucka-Kocka A. Dysregulations of MicroRNA and Gene Expression in Chronic Venous Disease. J Clin Med 2020;9:E1251. [PMID: 32344947 DOI: 10.3390/jcm9051251] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
11 Solá Ldel R, Aceves M, Dueñas AI, González-Fajardo JA, Vaquero C, Crespo MS, García-Rodríguez C. Varicose veins show enhanced chemokine expression. Eur J Vasc Endovasc Surg 2009;38:635-41. [PMID: 19729323 DOI: 10.1016/j.ejvs.2009.07.021] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
12 Ortega MA, Fraile-Martínez O, García-Montero C, Pekarek L, Alvarez-Mon MA, Guijarro LG, Del Carmen Boyano M, Sainz F, Álvarez-Mon M, Buján J, García-Honduvilla N, Asúnsolo Á. Tissue remodelling and increased DNA damage in patients with incompetent valves in chronic venous insufficiency. J Cell Mol Med 2021;25:7878-89. [PMID: 34148301 DOI: 10.1111/jcmm.16711] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Oklu R, Habito R, Mayr M, Deipolyi AR, Albadawi H, Hesketh R, Walker TG, Linskey KR, Long CA, Wicky S, Stoughton J, Watkins MT. Pathogenesis of Varicose Veins. Journal of Vascular and Interventional Radiology 2012;23:33-9. [DOI: 10.1016/j.jvir.2011.09.010] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
14 Studennikova VV, Severgina LO, Dzyundzya AN, Korovin IA. [Lower extremity varicose veins in childhood and at a young age: Mechanism of development and specific features]. Arkh Patol 2017;79:56-60. [PMID: 28792000 DOI: 10.17116/patol201779456-60] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
15 Smetanina MA, Kel AE, Sevost'ianova KS, Maiborodin IV, Shevela AI, Zolotukhin IA, Stegmaier P, Filipenko ML. DNA methylation and gene expression profiling reveal MFAP5 as a regulatory driver of extracellular matrix remodeling in varicose vein disease. Epigenomics 2018;10:1103-19. [PMID: 30070582 DOI: 10.2217/epi-2018-0001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
16 Ortega MA, Fraile-Martínez O, García-Montero C, Álvarez-Mon MA, Chaowen C, Ruiz-Grande F, Pekarek L, Monserrat J, Asúnsolo A, García-Honduvilla N, Álvarez-Mon M, Bujan J. Understanding Chronic Venous Disease: A Critical Overview of Its Pathophysiology and Medical Management. J Clin Med 2021;10:3239. [PMID: 34362022 DOI: 10.3390/jcm10153239] [Reference Citation Analysis]
17 Gheorghe SR, Vermeer C, Olteanu G, Silaghi CN, Crăciun AM. The Active Isoforms of MGP Are Expressed in Healthy and Varicose Veins without Calcification. J Clin Med 2021;10:5896. [PMID: 34945192 DOI: 10.3390/jcm10245896] [Reference Citation Analysis]
18 Nitschke Y, Hartmann S, Torsello G, Horstmann R, Seifarth H, Weissen-Plenz G, Rutsch F. Expression of NPP1 is regulated during atheromatous plaque calcification. J Cell Mol Med 2011;15:220-31. [PMID: 20015201 DOI: 10.1111/j.1582-4934.2009.00988.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
19 Cozzolino M, Mangano M, Galassi A, Ciceri P, Messa P, Nigwekar S. Vitamin K in Chronic Kidney Disease. Nutrients 2019;11:E168. [PMID: 30646590 DOI: 10.3390/nu11010168] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
20 Zaragatski E, Grommes J, Schurgers LJ, Langer S, Kennes L, Tamm M, Koeppel TA, Kranz J, Hackhofer T, Arakelyan K, Jacobs MJ, Kokozidou M. Vitamin K antagonism aggravates chronic kidney disease-induced neointimal hyperplasia and calcification in arterialized veins: role of vitamin K treatment? Kidney Int 2016;89:601-11. [PMID: 26466318 DOI: 10.1038/ki.2015.298] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
21 Lim CS, Kiriakidis S, Paleolog EM, Davies AH. Increased activation of the hypoxia-inducible factor pathway in varicose veins. Journal of Vascular Surgery 2012;55:1427-1439.e1. [DOI: 10.1016/j.jvs.2011.10.111] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
22 Kanta J, Zavadakova A. Role of fibronectin in chronic venous diseases: A review. Vasc Med 2020;25:588-97. [PMID: 32877311 DOI: 10.1177/1358863X20947789] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Yan L, Tang J, Hu X, Xu Y, Li K, Liu H, Nie Z, Chu H, Zhong Y. Imbalance in matrix metalloproteinases and tissue inhibitor of metalloproteinases from splenic veins and great saphenous veins under high hemodynamics. Phlebology 2020;35:18-26. [PMID: 31018823 DOI: 10.1177/0268355519842432] [Reference Citation Analysis]
24 Johnson EC, Doser TA, Cepurna WO, Dyck JA, Jia L, Guo Y, Lambert WS, Morrison JC. Cell proliferation and interleukin-6-type cytokine signaling are implicated by gene expression responses in early optic nerve head injury in rat glaucoma. Invest Ophthalmol Vis Sci 2011;52:504-18. [PMID: 20847120 DOI: 10.1167/iovs.10-5317] [Cited by in Crossref: 74] [Cited by in F6Publishing: 83] [Article Influence: 6.7] [Reference Citation Analysis]
25 Donaldson MS. Vitamin K: The missing link to prostate health. Medical Hypotheses 2015;84:219-22. [DOI: 10.1016/j.mehy.2014.12.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Gheorghe SR, Crăciun AM. Matrix Gla protein in tumoral pathology. Clujul Med 2016;89:319-21. [PMID: 27547048 DOI: 10.15386/cjmed-579] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
27 Kowalewski R, Malkowski A, Sobolewski K, Gacko M. Evaluation of aFGF/bFGF and FGF signaling pathway in the wall of varicose veins. J Surg Res 2009;155:165-72. [PMID: 19394961 DOI: 10.1016/j.jss.2008.07.032] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
28 Golledge J, Clancy P, Maguire J, Lincz L, Koblar S. The role of tenascin C in cardiovascular disease. Cardiovasc Res 2011;92:19-28. [PMID: 21712412 DOI: 10.1093/cvr/cvr183] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 4.6] [Reference Citation Analysis]
29 Ortega MA, Asúnsolo Á, Pekarek L, Alvarez-Mon MA, Delforge A, Sáez MA, Coca S, Sainz F, Mon MÁ, Buján J, García-Honduvilla N. Histopathological study of JNK in venous wall of patients with chronic venous insufficiency related to osteogenesis process. Int J Med Sci 2021;18:1921-34. [PMID: 33850461 DOI: 10.7150/ijms.54052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Saberianpour S, Modaghegh MHS, Rahimi H, Kamyar MM. Role of mechanosignaling on pathology of varicose vein. Biophys Rev 2021;13:139-45. [PMID: 33747248 DOI: 10.1007/s12551-021-00783-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Xu J, Shi GP. Vascular wall extracellular matrix proteins and vascular diseases. Biochim Biophys Acta 2014;1842:2106-19. [PMID: 25045854 DOI: 10.1016/j.bbadis.2014.07.008] [Cited by in Crossref: 156] [Cited by in F6Publishing: 141] [Article Influence: 19.5] [Reference Citation Analysis]
32 Pocock ES, Alsaigh T, Mazor R, Schmid-Schönbein GW. Cellular and molecular basis of Venous insufficiency. Vasc Cell 2014;6:24. [PMID: 25520775 DOI: 10.1186/s13221-014-0024-5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
33 Anwar M, Shalhoub J, Vorkas P, Lim C, Want E, Nicholson J, Holmes E, Davies A. In-vitro Identification of Distinctive Metabolic Signatures of Intact Varicose Vein Tissue via Magic Angle Spinning Nuclear Magnetic Resonance Spectroscopy. European Journal of Vascular and Endovascular Surgery 2012;44:442-50. [DOI: 10.1016/j.ejvs.2012.05.020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
34 Alsaigh T, Fukaya E. Varicose Veins and Chronic Venous Disease. Cardiol Clin 2021;39:567-81. [PMID: 34686268 DOI: 10.1016/j.ccl.2021.06.009] [Reference Citation Analysis]
35 Jian F, Chu H, Liu G, Zhao J, Xu Y, Wang T, Sun H, Tang J, Guo W, Wu H, Zhang S. Morphological characteristics of the walls of thrombophlebitic saphenous vein. Phlebology 2014;29:164-70. [DOI: 10.1177/0268355512472135] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
36 Jin Y, Xu G, Huang J, Zhou D, Huang X, Shen L. Analysis of the association between an insertion/deletion polymorphism within the 3' untranslated region of COL1A2 and chronic venous insufficiency. Ann Vasc Surg 2013;27:959-63. [PMID: 23849651 DOI: 10.1016/j.avsg.2013.04.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
37 Grant Y, Onida S, Davies A. Genetics in chronic venous disease. Phlebology 2017;32:3-5. [PMID: 26786554 DOI: 10.1177/0268355515624030] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
38 Ueland T, Dahl C, Gullestad L, Aakhus S, Broch K, Skåardal R, Vermeer C, Aukrust P, Schurgers L. Circulating levels of non-phosphorylated undercarboxylated matrix Gla protein are associated with disease severity in patients with chronic heart failure. Clinical Science 2011;121:119-27. [DOI: 10.1042/cs20100589] [Cited by in Crossref: 46] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]